BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
6 results:

  • 1. Parathyroid carcinoma: Report of 10 patients and literature review.
    Miao XY; Wang XL; Lyu ZH; Ba JM; Pei Y; Dou JT; Gu WJ; Du J; Guo QH; Chen K; Mu YM
    Neuro Endocrinol Lett; 2022 Nov; 43(4):233-238. PubMed ID: 36528886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
    Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
    Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
    Sonpavde G; Manitz J; Gao C; Tayama D; Kaiser C; Hennessy D; Makari D; Gupta A; Abdullah SE; Niegisch G; Rosenberg JE; Bajorin DF; Grivas P; Apolo AB; Dreicer R; Hahn NM; Galsky MD; Necchi A; Srinivas S; Powles T; Choueiri TK; Pond GR
    J Urol; 2020 Dec; 204(6):1173-1179. PubMed ID: 32552295
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
    Hu CY; Mohtat D; Yu Y; Ko YA; Shenoy N; Bhattacharya S; Izquierdo MC; Park AS; Giricz O; Vallumsetla N; Gundabolu K; Ware K; Bhagat TD; Suzuki M; Pullman J; Liu XS; Greally JM; Susztak K; Verma A
    Clin Cancer Res; 2014 Aug; 20(16):4349-60. PubMed ID: 24916699
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma].
    Hong YP; Yao XD; Zhu Y; Ye DW; Shi GH; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu YP; Ma CG; Xiao WJ; Qin XJ; Lin GW
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2880-3. PubMed ID: 24373400
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.